NexImmune (NEXI) Short Interest Ratio & Short Volume $0.21 -0.01 (-6.42%) (As of 11:55 AM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NexImmune Short Interest DataNexImmune (NEXI) has a short interest of 16,000 shares, representing 1.39% of the float (the number of shares available for trading by the public). This marks a -3.61% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 846,679 shares to cover all short positions.Current Short Interest16,000 sharesPrevious Short Interest16,600 sharesChange Vs. Previous Month-3.61%Dollar Volume Sold Short$44,158.40Short Interest Ratio0.9 Days to CoverLast Record DateJune 30, 2024Outstanding Shares1,395,000 sharesFloat Size1,150,000 sharesShort Percent of Float1.39%Today's Trading Volume884 sharesAverage Trading Volume846,679 sharesToday's Volume Vs. Average0% Short Selling NexImmune? Sign up to receive the latest short interest report for NexImmune and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNEXI Short Interest Over TimeNEXI Days to Cover Over TimeNEXI Percentage of Float Shorted Over Time Ad Porter & CompanyThis is treasonIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. NexImmune Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202416,000 shares $44,158.40 -3.6%1.4%0.9 $2.76 6/15/202416,600 shares $48,970.00 +35.0%1.4%0.9 $2.95 5/31/202412,300 shares $37,638.00 +5.1%1.1%0.5 $3.06 5/15/202411,700 shares $40,540.50 +88.7%1.0%0.2 $3.47 4/30/20246,200 shares $20,832.00 -23.5%0.6%0.1 $3.36 4/15/20248,100 shares $28,755.00 -54.5%0.9%0 $3.55 Get the Latest News and Ratings for NEXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter. 3/31/202417,800 shares $99,858.00 -49.4%2.3%0 $5.61 3/15/202435,200 shares $203,808.00 +122.8%4.5%0 $5.79 2/29/202415,800 shares $105,860.00 -63.4%2.2%0 $6.70 2/15/202443,200 shares $364,608.00 -69.5%5.9%0 $8.44 1/31/2024141,400 shares $2.12 million -2.8%21.5%0.1 $15.00 1/15/2024145,400 shares $1.45 million +513.5%22.1%0.1 $9.96 12/31/202323,700 shares $52,614.00 -33.6%3.6%0 $2.22 12/15/202335,700 shares $87,822.00 +526.3%5.4%0.1 $2.46 11/30/20235,700 shares $14,136.00 -12.3%0.9%0 $2.48 11/15/20236,500 shares $15,860.00 -25.3%1.0%0.4 $2.44 10/31/20238,700 shares $32,364.00 +45.0%1.4%0.7 $3.72 10/15/20236,000 shares $28,545.00 -95.6%0.9%1.1 $4.76 9/30/2023134,900 shares $28,315.51 +21.3%0.9%1.6 $0.21 9/15/2023111,200 shares $28,912.00 +34.5%0.7%1.2 $0.26 8/31/202382,700 shares $17,706.07 -59.0%0.5%0.6 $0.21 8/15/2023201,600 shares $49,593.60 +5.7%1.3%1.2 $0.25 7/31/2023190,800 shares $55,389.24 -33.5%1.2%0.7 $0.29 7/15/2023286,700 shares $77,695.70 -19.3%1.8%1 $0.27 6/30/2023355,400 shares $100,151.72 +47.7%2.3%1.3 $0.28 6/15/2023240,600 shares $78,483.72 -24.2%1.5%0.8 $0.33 5/31/2023317,200 shares $101,662.60 +49.2%2.0%1.3 $0.32 5/15/2023212,600 shares $59,549.26 -0.6%1.3%0.8 $0.28 4/30/2023213,900 shares $77,239.29 -32.0%1.4%0.2 $0.36 4/15/2023314,700 shares $121,190.97 -7.3%2.0%0.3 $0.39 3/31/2023339,500 shares $129,010.00 -1.3%2.1%0.3 $0.38 3/15/2023344,000 shares $142,106.40 -18.1%2.0%0.3 $0.41 2/28/2023419,800 shares $180,514.00 +67.2%2.3%0.3 $0.43 2/15/2023251,100 shares $102,951.00 -3.1%1.4%0.2 $0.41 1/31/2023259,100 shares $105,350.06 +12.7%1.4%1 $0.41 1/15/2023229,900 shares $91,960.00 -42.1%1.2%0.9 $0.40 12/30/2022397,300 shares $96,583.63 +2.8%2.1%1.7 $0.24 12/15/2022386,600 shares $115,284.12 -3.8%2.1%2 $0.30 11/30/2022401,900 shares $178,041.70 -38.4%2.2%1.4 $0.44 11/15/2022652,500 shares $296,822.25 -13.9%3.5%0.9 $0.45Rigged election? (Ad)Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. Watch this video, it is being taken down Monday night 10/31/2022758,100 shares $530,745.81 -13.9%4.4%1.1 $0.70 10/15/2022880,900 shares $615,749.10 -8.6%5.1%1.2 $0.70 9/30/2022963,700 shares $534,468.02 +29.4%5.5%0.6 $0.55 9/15/2022745,000 shares $584,750.50 +38.4%4.8%0.4 $0.78 8/31/2022538,500 shares $635,430.00 +13.2%3.6%0.3 $1.18 8/15/2022475,800 shares $599,508.00 +8.2%3.4%0.4 $1.26 7/31/2022439,800 shares $505,770.00 -3.5%3.1%0.4 $1.15 7/15/2022455,600 shares $833,748.00 -12.0%3.2%0.4 $1.83 6/30/2022517,700 shares $833,497.00 -48.2%3.6%2.9 $1.61 6/15/20221,000,000 shares $2.05 million -3.9%7.0%4.1 $2.05 5/31/20221,040,000 shares $2.37 million +9.1%7.2%4.2 $2.28 5/15/2022953,100 shares $1.92 million +7.6%6.6%4.2 $2.01 4/30/2022885,900 shares $1.87 million +8.8%6.1%3.9 $2.11 4/15/2022814,500 shares $2.42 million -5.8%5.6%3.8 $2.97 3/31/2022865,000 shares $3.64 million +46.6%6.0%4.5 $4.21 3/15/2022590,000 shares $1.13 million +7.8%4.0%5.1 $1.92 2/28/2022547,200 shares $1.36 million +5.1%3.7%5.8 $2.48 2/15/2022520,700 shares $1.30 million +9.0%3.2%6.8 $2.50 1/31/2022477,700 shares $1.51 million +13.2%2.9%7.6 $3.17 1/15/2022422,100 shares $1.57 million +5.5%2.6%8.2 $3.71 12/31/2021400,300 shares $1.85 million -5.2%2.4%8.2 $4.61 12/15/2021422,300 shares $2.21 million -2.2%2.6%8.5 $5.24 11/30/2021431,800 shares $3.41 million -6.2%2.6%5.9 $7.90 11/15/2021460,300 shares $4.66 million -4.7%2.8%5.5 $10.13 10/29/2021483,100 shares $5.50 million -5.4%2.9%5.4 $11.38 10/15/2021510,900 shares $6.55 million -14.2%3.1%5.9 $12.82 9/30/2021595,700 shares $9.02 million +94.1%3.6%7 $15.14 9/15/2021306,900 shares $4.89 million +4.3%1.9%3.8 $15.93 8/31/2021294,200 shares $4.14 million -1.9%1.8%5.6 $14.08 8/13/2021299,800 shares $4.25 million No Change1.8%8.2 $14.19 NEXI Short Interest - Frequently Asked Questions What is NexImmune's current short interest? Short interest is the volume of NexImmune shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 16,000 shares of NEXI short. 1.39% of NexImmune's shares are currently sold short. Learn More on NexImmune's current short interest. What is a good short interest ratio for NexImmune? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NEXI shares currently have a short interest ratio of 1.0. Learn More on NexImmune's short interest ratio. What is a good short interest percentage for NexImmune? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.39% of NexImmune's floating shares are currently sold short. Is NexImmune's short interest increasing or decreasing? NexImmune saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 16,000 shares, a drop of 3.6% from the previous total of 16,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NexImmune's float size? NexImmune currently has issued a total of 1,395,000 shares. Some of NexImmune's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NexImmune currently has a public float of 1,150,000 shares. How does NexImmune's short interest compare to its competitors? 1.39% of NexImmune's shares are currently sold short. Here is how the short interest of companies compare to NexImmune: CERo Therapeutics Holdings, Inc. (1.07%), PaxMedica, Inc. (4.65%), Qualigen Therapeutics, Inc. (0.45%), Aptevo Therapeutics Inc. (1.64%), Salarius Pharmaceuticals, Inc. (0.11%), TC Biopharm (Holdings) Plc (3.13%), Dermata Therapeutics, Inc. (1.93%), Altamira Therapeutics Ltd. (0.31%), Smart for Life, Inc. (11.90%), China SXT Pharmaceuticals, Inc. (5.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks. What does it mean to sell short NexImmune stock? Short selling NEXI is an investing strategy that aims to generate trading profit from NexImmune as its price is falling. NEXI shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NexImmune? A short squeeze for NexImmune occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NEXI, which in turn drives the price of the stock up even further. How often is NexImmune's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NEXI, twice per month. The most recent reporting period available is June, 30 2024. More Short Interest Resources from MarketBeat Related Companies CERo Therapeutics Short Interest Data PaxMedica Short Interest Data Qualigen Therapeutics Short Interest Data Aptevo Therapeutics Short Interest Data Salarius Pharmaceuticals Short Interest Data TC Biopharm Short Interest Data Dermata Therapeutics Short Interest Data Altamira Therapeutics Short Interest Data Smart for Life Short Interest Data China SXT Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NEXI) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexImmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
